Yan-jun J. Xiang - Publications

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Journal: Gut

Published: February 10, 2026

ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development.

Journal: Cancer research

Published: November 06, 2025

Adjuvant Sintilimab with or without Anti-VEGF Therapy After Resection in Hepatocellular Carcinoma with Microvascular Invasion: A Multicenter Retrospective Study.

Journal: Journal of hepatocellular carcinoma

Published: July 30, 2025

Transarterial chemoembolization combined with immune checkpoint inhibitors and anti-VEGF agents for intermediate HCC: a multicenter study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 25, 2025

PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

Journal: Journal for immunotherapy of cancer

Published: July 19, 2025

Development of a new nomogram for predicting recurrence in HCC with MVI following curative hepatectomy.

Journal: International journal of surgery (London, England)

Published: June 16, 2025

Development of a new nomogram for predicting recurrence in HCC With MVI following curative hepatectomy.

Journal: International journal of surgery (London, England)

Published: June 16, 2025

Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 05, 2024

Adjuvant transarterial chemoembolization plus lenvatinib for patients with HCC with MVI after resection: a multicenter retrospective study.

Journal: The oncologist

Published: March 08, 2024

Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence.

Journal: Technology in cancer research & treatment

Published: November 07, 2023

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Journal: Nature medicine

Published: September 20, 2023

Discovery of distinct cancer cachexia phenotypes using an unsupervised machine-learning algorithm.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: August 01, 2023